Original news and analysis on international IP policy
WASHINGTON, DC -- The sun may be setting on multilateral policymaking in intellectual property in the eyes of industry, but leading United States and European Union representatives insist on its continued vital role in trade and economy. But a “new narrative” is needed as they emphasise bilateral and plurilateral agreements.
The TPP is done, or not quite. But what is still lacking, what are next steps and what does the finalised deal do to the grand picture of the mega-trade deal landscape? Japanese economist Nakagawa Junji, Professor of International Economic Law Institute of Social Science, University of Tokyo, shares a view from Japan with writer Monika Ermert.
Four weeks after the finalisation of the agreement, the final text of the Trans-Pacific Partnership (TPP) was finally released by the United States and other partners of the first of the regional mega-trade deals. The parties hurried to underline the success of the negotiations, but early reactions were deeply divided.
The trade ministers of the United States and India yesterday reviewed work from the past year on a full range of intellectual property issues and made new commitments, as part of their larger bilateral trade policy forum. Among the issues was a commitment to work for access to medicines, increase work on trade secrets, and deepen copyright cooperation in acknowledgement of the two biggest entertainment industries in the world.
The Office of the United States Trade Representative (USTR) next week is expected to provide justification for withholding from a Freedom of Information Act request the communications with its industry advisors as confidential commercial or financial information. The case involves communications in the lead-up to completion of the Trans-Pacific Partnership (TPP) agreement, and could set a precedent for exemptions of communications with lobbyists.
At the conclusion of another round of talks for a bilateral trade agreement in Miami today, Europe and the United States negotiators said they remain far apart on the issue of protection of geographical indications. But they made progress on pharmceuticals and medical products, they said.
The Trans-Pacific Partnership (TPP) Agreement contains an important provision concerning achieving balance in the copyright systems of the twelve countries party to that free trade agreement. This provision was not present in the early draft of the agreement. Then, in…
An Organisation for Economic Cooperation and Development (OECD) report released today sets out principles governments can adopt to boost innovation, thereby increasing productivity and economic growth.
The health ministers of the Group of Seven (G7) most developed countries have issued a declaration on antimicrobial resistance and Ebola. The governments said they would explore innovative economic incentives to promote research and development of new antibiotics, such as a global antibiotic research fund and a market entry reward mechanism.
The Transatlantic Trade and Investment Partnership should expressly include an international treaty on cultural diversity, public broadcasters and a coalition have said.
Reactions to yesterday's announcement that the Trans-Pacific Partnership (TPP) is in the books quickly turned to “what's next?” with European Commissioner Cecilia Malmstroem sending congratulations and expressing expectations that “with TPP done, we will be able to approach our TTIP negotiations with an even greater focus from both sides.” But considerable work remains for TPP to come into effect.
Free trade agreements should include incentives for generic and biosimilar medicines, speakers said at a panel during the World Trade Organization Public Forum last week.